Thomas F. Deuel, M.D., Director
owned no shares of the Company's stock, nor did he
have any options at June 30, 2008.
The Board of Directors, acting upon the unanimous recommendation of its Nominating and Corporate Governance Committee
, has nominated Mr. John E. Celentano, Dr. Alexander J. Denner, Dr. Thomas F. Deuel
, Mr. Jules Haimovitz, Mr. Carl C. Icahn, Mr. John H. Johnson, Dr. Peter S. Liebert, Dr. Richard C. Mulligan, Dr. David Sidransky and Dr. Charles Woler for election as directors at the Annual Meeting.
...Thomas F. Deuel, M.D.(1)(2)
...Thomas F. Deuel, M.D., has served as a director of the Company since July 3, 2007.Since February 2002, Dr. Deuel has served as a Professor of Molecular and Experimental Medicine and Cell Biology, Director of the Division of Molecular Oncology, Department of Molecular and Experimental Medicine, and Director of the Vascular Biology Affinity Group at The Scripps Research Institute.Also, since 1998, Dr. Deuel has served as a Professor of Medicine at Harvard Medical School.He is currently a Professor Emeritus at Harvard Medical School.In addition, from 1996 to 2002, Dr. Deuel served as a Director, Division of Growth Regulation at Beth Israel Hospital, Boston, Massachusetts and, prior to that, was a Professor of Medicine and Biochemistry and the head of Oncology Services at the Washington University School of Medicine, St. Louis, Missouri.He is a member of the Institute of Medicine at the National Academy of Sciences.Dr. Deuel is also President of the Edward R. Mallinckrodt Foundation, St. Louis, Missouri.He has served on different editorial boards, including the Journal of Clinical Investigation and Blood, and currently is on the Editorial Board of Current Opinion in Hematology and Section Editor for Vascular Biology.Dr. Deuel has served and continues to serve on numerous scientific advisory boards for various companies, including the Company's scientific advisory board during its existence.
In addition, Dr. Deuel
has earned many professional honors and awards.Dr. Deuel holds an M.D. from Columbia University and an A.B. from Princeton University.
(Chairman), Alexander J. Denner, Thomas F. Deuel
, Jules Haimovitz and Carl C. Icahn.
Denner, Thomas F. Deuel
, Richard C. Mulligan and Charles Woler.